TScan Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell TCRX and other ETFs, options, and stocks.

About TCRX

TScan Therapeutics, Inc. discovers and develops transformative T cell therapies (TCR-T) to treat liquid cancers, solid tumors and other serious diseases. Its platform identifies previously uncharacterized, clinically-derived shared T cell antigens and all off-target TCR interactions, to enable the development of efficacious TCR-Ts.

CEO

Gavin MacBeath

CEOGavin MacBeath

Employees

154

Employees154

Headquarters

Waltham, Massachusetts

HeadquartersWaltham, Massachusetts

Founded

2018

Founded2018

Employees

154

Employees154

TCRX Key Statistics

Market cap

309.25M

Market cap309.25M

Price-Earnings ratio

-3.95

Price-Earnings ratio-3.95

Dividend yield

—

Dividend yield—

Average volume

1.00M

Average volume1.00M

High today

—

High today—

Low today

—

Low today—

Open price

$6.18

Open price$6.18

Volume

0.00

Volume0.00

52 Week high

$9.69

52 Week high$9.69

52 Week low

$1.93

52 Week low$1.93

Analyst ratings

100%

of 7 ratings

Buy

100%

Hold

Sell